Investing Profile

Elliott Sigal

InvestorAngel
Advisor and Board Member in Biotechnology
Princeton, New Jersey
Photo of Elliott Sigal, Angel

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
New Enterprise Associates (NEA) Network
42 CONNECTIONS
Purdue University Network
40 CONNECTIONS
University of Chicago Network
40 CONNECTIONS
Purdue University Network
40 CONNECTIONS
Purdue University Network
40 CONNECTIONS
cb
Angel
$5K - $50K
$25K
2
CompanyStageDateRound SizeTotal Raised
Mersana Therapeutics
Series BMar 2015$35M
$110M
Co-investors: Sara Nayeem (Avoro Ventures), David Parkinson
Surface Oncology
Series AJan 2015$35M
$35M
Co-investors: Michael Gladstone (Atlas Venture)
Board Member Alnylam Pharmaceuticals2022 - Present
Board Member Vir Biotechnology, Inc.2020 - Present
Board Member Surface Oncology Inc.2018 - Present
Co-Chair, Scientific Advisory Board Amgen2015 - Present
Board Member Adaptimmune US2014 - Present
Senior Advisor New Enterprise Associates (NEA)2014 - 2023
Board Member Melanoma Research Alliance2013 - 2023
Board Member Spark Therapeutics, Inc.2014 - 2019
Board Member Bristol-Myers Squibb2011 - 2013
Chief Scientific Officer and Executive Vice President Bristol-Myers Squibb2004 - 2013
Purdue University Master of Science (MS) Industrial Engineering
University of Chicago Doctor of Medicine (M.D.) Medicine
Purdue University Doctor of Philosophy (Ph.D.) Industrial Engineering
Purdue University Bachelor of Science (BS) Industrial Engineering